+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Topical Drugs Market by Product, End-use - Global Forecast 2025-2030- Product Image
Topical Drugs Market by Product, End-use - Global Forecast 2025-2030- Product Image
Sale

Topical Drugs Market by Product, End-use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666377
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Topical Drugs Market grew from USD 15.44 billion in 2023 to USD 16.86 billion in 2024. It is expected to continue growing at a CAGR of 9.64%, reaching USD 29.43 billion by 2030.

Topical drugs are pharmaceutical formulations applied directly onto the skin or mucous membranes to treat localized conditions or act through transdermal delivery. Their scope encompasses a range of applications, including pain management, dermatological conditions, anti-inflammatory needs, and localized infections. The necessity for topical drugs lies in their ability to provide targeted relief with minimal systemic side effects, offering a direct mode of drug delivery that enhances efficacy and patient compliance. These drugs are applied in settings ranging from self-care at home to professional medical environments, ensuring their wide end-use scope across patients with varying health conditions.

The market for topical drugs is driven by key factors such as the rising prevalence of skin diseases, aging populations, and the demand for non-invasive treatment options. Advances in drug formulation technologies, like nanoparticles and microemulsions, are creating new opportunities for more effective treatments with enhanced bioavailability and penetration capabilities. Furthermore, the trend toward personalized medicine and the development of combination therapies are poised to expand market potential significantly. However, limitations include possible skin reactions, stringent regulatory requirements, and issues with patient adherence to therapy regimens that challenge market growth. Additionally, the competition from alternative therapies, such as oral medications and injectable drugs, poses a significant restraint.

Innovative areas for research and business growth include the development of bioactive compounds and green chemistry-based formulations that align with increasing consumer demand for sustainable and natural products. Exploring the possibilities of digital health integration, like smart drug delivery systems and AI-driven personalized treatment plans, can also provide a competitive edge. Companies are encouraged to invest in R&D for these promising technologies, work towards improving delivery mechanisms, and focus on expanding their geographical footprint in emerging markets to capitalize on untapped potential. Overall, navigating regulatory landscapes while fostering innovation is crucial for sustained growth in the dynamic market of topical drugs.

Understanding Market Dynamics in the Topical Drugs Market

The Topical Drugs Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising incidence of skin disorders, and diabetes
    • Increasing demand for self-administered drugs and steroid-free topical medication
    • Favorable government approvals for topical drugs
  • Market Restraints
    • Irritations and allergies associated with topical treatments
  • Market Opportunities
    • Innovation in topical drug formulations
    • Advancements in drug delivery systems
  • Market Challenges
    • Complex formulations of topical drugs

Exploring Porter’s Five Forces for the Topical Drugs Market

Porter’s Five Forces framework further strengthens the insights of the Topical Drugs Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Topical Drugs Market

External macro-environmental factors deeply influence the performance of the Topical Drugs Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Topical Drugs Market

The Topical Drugs Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Topical Drugs Market

The Topical Drugs Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Topical Drugs Market

The Topical Drugs Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Topical Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Almirall, S.A, Bausch Health Companies Inc., Bayer AG, Cigna Health and Life Insurance Company, Concert Pharmaceuticals, Eli Lilly and Company, GlaxoSmithkline PLC, Hisamitsu Pharmaceuticals Co. Inc., Johnson & Johnson Services, Inc., LEO Pharma A/S, Lupin Limited, Mayne Pharma Group Limited, Mylan N.V., and Tergus Pharma.

Market Segmentation & Coverage

This research report categorizes the Topical Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Liquid Formulations
      • Solutions
      • Suspensions
    • Semi-Solid Formulations
      • Creams
      • Gel
      • Lotions
      • Ointments
      • Pastes
    • Solid Formulations
      • Powders
      • Suppositories
    • Transdermal Products
      • Transdermal Patches
      • Transdermal Semi-Solids
  • End-use
    • Burn Centers
    • Home Care Settings
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of skin disorders, and diabetes
5.1.1.2. Increasing demand for self-administered drugs and steroid-free topical medication
5.1.1.3. Favorable government approvals for topical drugs
5.1.2. Restraints
5.1.2.1. Irritations and allergies associated with topical treatments
5.1.3. Opportunities
5.1.3.1. Innovation in topical drug formulations
5.1.3.2. Advancements in drug delivery systems
5.1.4. Challenges
5.1.4.1. Complex formulations of topical drugs
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Topical Drugs Market, by Product
6.1. Introduction
6.2. Liquid Formulations
6.2.1. Solutions
6.2.2. Suspensions
6.3. Semi-Solid Formulations
6.3.1. Creams
6.3.2. Gel
6.3.3. Lotions
6.3.4. Ointments
6.3.5. Pastes
6.4. Solid Formulations
6.4.1. Powders
6.4.2. Suppositories
6.5. Transdermal Products
6.5.1. Transdermal Patches
6.5.2. Transdermal Semi-Solids
7. Topical Drugs Market, by End-use
7.1. Introduction
7.2. Burn Centers
7.3. Home Care Settings
7.4. Hospitals & Clinics
8. Americas Topical Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Topical Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Topical Drugs Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. TOPICAL DRUGS MARKET RESEARCH PROCESS
FIGURE 2. TOPICAL DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL TOPICAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL TOPICAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL TOPICAL DRUGS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL TOPICAL DRUGS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. TOPICAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. TOPICAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. TOPICAL DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL TOPICAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TOPICAL DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. TOPICAL DRUGS MARKET DYNAMICS
TABLE 7. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TOPICAL DRUGS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TOPICAL DRUGS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TOPICAL DRUGS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PASTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TOPICAL DRUGS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SUPPOSITORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL SEMI-SOLIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TOPICAL DRUGS MARKET SIZE, BY BURN CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TOPICAL DRUGS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TOPICAL DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 50. CANADA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. CANADA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 52. CANADA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 53. CANADA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 54. CANADA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 55. CANADA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. MEXICO TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 58. MEXICO TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 59. MEXICO TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 60. MEXICO TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 82. CHINA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. CHINA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 84. CHINA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 85. CHINA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 86. CHINA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 87. CHINA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 88. INDIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. INDIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 90. INDIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 91. INDIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 92. INDIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 93. INDIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 100. JAPAN TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. JAPAN TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 102. JAPAN TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 103. JAPAN TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 104. JAPAN TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 105. JAPAN TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 136. THAILAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. THAILAND TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 138. THAILAND TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 139. THAILAND TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 140. THAILAND TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 141. THAILAND TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 155. DENMARK TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. DENMARK TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 157. DENMARK TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 158. DENMARK TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 159. DENMARK TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 160. DENMARK TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 161. EGYPT TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. EGYPT TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 163. EGYPT TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 164. EGYPT TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 165. EGYPT TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 166. EGYPT TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 167. FINLAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. FINLAND TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 169. FINLAND TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 170. FINLAND TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 171. FINLAND TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 172. FINLAND TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 173. FRANCE TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. FRANCE TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 175. FRANCE TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 176. FRANCE TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 177. FRANCE TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 178. FRANCE TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 179. GERMANY TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. GERMANY TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 181. GERMANY TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 182. GERMANY TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 183. GERMANY TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 184. GERMANY TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 191. ITALY TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. ITALY TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 193. ITALY TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 194. ITALY TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 195. ITALY TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 196. ITALY TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 209. NORWAY TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. NORWAY TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 211. NORWAY TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 212. NORWAY TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 213. NORWAY TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 214. NORWAY TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 215. POLAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. POLAND TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 217. POLAND TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 218. POLAND TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 219. POLAND TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 220. POLAND TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 221. QATAR TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. QATAR TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 223. QATAR TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 224. QATAR TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 225. QATAR TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 226. QATAR TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 245. SPAIN TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 246. SPAIN TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 247. SPAIN TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 248. SPAIN TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 249. SPAIN TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 250. SPAIN TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 263. TURKEY TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. TURKEY TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 265. TURKEY TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 266. TURKEY TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 267. TURKEY TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 268. TURKEY TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 281. TOPICAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 282. TOPICAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Topical Drugs Market, which are profiled in this report, include:
  • AbbVie Inc.
  • Almirall, S.A
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cigna Health and Life Insurance Company
  • Concert Pharmaceuticals
  • Eli Lilly and Company
  • GlaxoSmithkline PLC
  • Hisamitsu Pharmaceuticals Co. Inc.
  • Johnson & Johnson Services, Inc.
  • LEO Pharma A/S
  • Lupin Limited
  • Mayne Pharma Group Limited
  • Mylan N.V.
  • Tergus Pharma

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 16.86 Billion
Forecasted Market Value ( USD ) by 2030 $ 29.43 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Topical Drug Delivery Market by Product, Rout to Administration, End-User - Global Forecast 2025-2030 - Product Image

Topical Drug Delivery Market by Product, Rout to Administration, End-User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Topical Drug Delivery - Global Strategic Business Report - Product Image

Topical Drug Delivery - Global Strategic Business Report

  • Report
  • 94 Pages
  • Global
From
Topical Drug Delivery Global Market Report 2024 - Product Image

Topical Drug Delivery Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Topical Drug Delivery Market Market By Product, By Route Of Administration, Regional Outlook - Global Forecast up to 2030 - Product Image

Topical Drug Delivery Market Market By Product, By Route Of Administration, Regional Outlook - Global Forecast up to 2030

  • Report
  • 116 Pages
  • Global
From
Topical Drugs Contract Development and Manufacturing Organization (CDMO) Global Market Report 2024 - Product Image

Topical Drugs Contract Development and Manufacturing Organization (CDMO) Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From

About the Ointment Market

The Ointment market within the context of Over the Counter (OTC) Drugs is a large and diverse industry. Ointments are topical medications used to treat a variety of skin conditions, such as eczema, psoriasis, and acne. Ointments are typically composed of a combination of oils, waxes, and other ingredients, and are applied directly to the skin. Ointments are available in a variety of forms, including creams, lotions, and gels. The Ointment market is highly competitive, with a wide range of products available from both large and small companies. Many of the leading Ointment manufacturers are multinational corporations, with products sold in countries around the world. In addition, there are a number of smaller, independent companies that specialize in Ointment products. Some of the leading companies in the Ointment market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Bayer. These companies produce a wide range of Ointment products, including creams, lotions, and gels. Other companies in the Ointment market include CVS, Walgreens, and Rite Aid. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.